Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium.
about
Amniotic fluid: Source of trophic factors for the developing intestineOntogeny of intestinal epithelial innate immune responsesNecrotizing enterocolitis: new insights into pathogenesis and mechanismsCiprofloxacin modulates cytokine/chemokine profile in serum, improves bone marrow repopulation, and limits apoptosis and autophagy in ileum after whole body ionizing irradiation combined with skin-wound traumaDiscovery and validation of a new class of small molecule Toll-like receptor 4 (TLR4) inhibitorsReactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation.Human perinatal immunity in physiological conditions and during infection.Animal models of gastrointestinal and liver diseases. Animal models of necrotizing enterocolitis: pathophysiology, translational relevance, and challenges.Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9.Evidence-based feeding strategies before and after the development of necrotizing enterocolitis.Update in pathogenesis and prospective in treatment of necrotizing enterocolitis.A holobiont birth narrative: the epigenetic transmission of the human microbiomeTransforming growth factor-β2 and endotoxin interact to regulate homeostasis via interleukin-8 levels in the immature intestine.Necrotizing enterocolitis in newborns: update in pathophysiology and newly emerging therapeutic strategies.Maturation of the enteric mucosal innate immune system during the postnatal period.Mucosal Immune Development in Early Life: Setting the Stage.Factors influencing gastrointestinal tract and microbiota immune interaction in preterm infants.Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptorThe human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestineToll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosisToll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis.A critical role for TLR4 induction of autophagy in the regulation of enterocyte migration and the pathogenesis of necrotizing enterocolitisMechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch.Innate immune signaling in the pathogenesis of necrotizing enterocolitis.Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling.Short-term surgical outcomes of preterm infants with necrotizing enterocolitis: A single-center experience.Amniotic fluid-borne hepatocyte growth factor protects rat pups against experimental necrotizing enterocolitisThe Role of Mucosal Immunity in the Pathogenesis of Necrotizing Enterocolitis.Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis.ErbB receptors and their growth factor ligands in pediatric intestinal inflammation.Stem cells as a potential therapy for necrotizing enterocolitis.Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis.Pathogenesis of necrotizing enterocolitis: modeling the innate immune response.Protective effects of amniotic fluid in the setting of necrotizing enterocolitis.Inflammation and Apoptosis: Dual Mediator Role for Toll-like Receptor 4 in the Development of Necrotizing Enterocolitis.LPS Induces Hyper-Permeability of Intestinal Epithelial Cells.Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.Surfactant protein-D attenuates the lipopolysaccharide-induced inflammation in human intestinal cells overexpressing toll-like receptor 4.Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing Enterocolitis.Cytokines and growth factors in the developing intestine and during necrotizing enterocolitis.
P2860
Q26766674-23CCF618-F053-41C5-9B8A-9D47D61CB240Q27004090-717087FD-F722-4534-9FFF-F4DD389A12B0Q28079458-63E93AB7-B839-4C26-89DB-BB24D81AA8BFQ28487821-BB95E34A-E56E-4B15-BBB1-EF9AC99706E9Q28533856-346A53B8-881A-4649-9825-68748AFCE371Q33584702-0AA6E322-9C92-4AB0-B133-040DB37787D5Q33591993-CA774C4A-ADFB-4CD0-B9AA-9E18B0860347Q33701575-F8089723-5F18-492B-8B3D-980188734727Q33701606-8F5858B5-7252-4B18-8764-C5DD3C457184Q33962474-F7BFB811-0F5D-4F12-B7B2-AA22586D2694Q34013912-B5F064B5-B40B-475A-951B-B46DE82E49B7Q34063116-374C285F-C9B8-46D6-BBCA-077E1B271185Q34664048-DB37083F-9D81-4358-8C9F-6895BC340AECQ35047413-5EA70B57-8BDF-4E6D-8E2C-CA78CD5086BDQ35190707-1FC9BA59-62B2-446E-A361-2A75DEEC8AF8Q35558518-3FA765E2-A602-45FF-82DB-49FF35EB39ABQ35575131-6E2EECC3-F014-45D2-8D29-FC061957A246Q35967645-E0D7A987-53C5-425C-B0A7-A2F5969A9945Q36127329-4F13AA5B-4309-4BA1-9AA5-9F702865D7AEQ36347820-5874FDAD-0B2F-456A-B8B0-AE89E28C531EQ36515093-76BBBBBC-59C4-41BE-B702-6A45B4FDA1B1Q36718260-BCC09CEF-C28D-460D-9090-F15B5634AEB5Q36817973-D9F2E692-BEFB-45B7-883E-1E2628182EF6Q36914228-354A7125-FEDB-464A-83CF-7148BD6D1D21Q36915561-988C2742-509D-4255-BB74-B8E31999CD9EQ37605694-9FF4F8E4-2539-45A4-9ABB-3ABF9501BA15Q37629131-3A80794B-E0FD-4D2C-B328-FBDE296D2C01Q37677906-C81039BC-0370-4E95-A404-6B41601C6561Q37683363-5D00B920-0F53-4302-9877-44044A769936Q37734240-07DDE1F6-BF96-4DF8-9817-5B511909A8C8Q38154935-DD4968B6-C2C0-48B2-B36F-79A1A7118F35Q38173600-903617F6-5E0D-487E-9765-B06F47D6D983Q38275103-7E469839-A7D1-4317-8DBD-33C2329D2723Q38671480-E3EA6200-261F-41F7-95BF-153D8C877A12Q38730870-0605AA04-1D01-4E6C-94AD-D96BD75ED8B7Q38735352-6C940003-C0CA-4AD0-B90B-3F2EB8D2F7E7Q38770059-2E3D561C-74FC-4448-9CDA-4AB67209C3C6Q38824140-7D7B2549-708E-4838-B6D8-A746CF781C86Q38955406-A16557EE-8DB8-488F-9ED9-E383460667D5Q39004825-7BCED51C-5896-45A8-8EBD-E8FA3A74293D
P2860
Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Amniotic fluid inhibits Toll-l ...... eonatal intestinal epithelium.
@ast
Amniotic fluid inhibits Toll-l ...... eonatal intestinal epithelium.
@en
type
label
Amniotic fluid inhibits Toll-l ...... eonatal intestinal epithelium.
@ast
Amniotic fluid inhibits Toll-l ...... eonatal intestinal epithelium.
@en
prefLabel
Amniotic fluid inhibits Toll-l ...... eonatal intestinal epithelium.
@ast
Amniotic fluid inhibits Toll-l ...... eonatal intestinal epithelium.
@en
P2093
P2860
P356
P1476
Amniotic fluid inhibits Toll-l ...... neonatal intestinal epithelium
@en
P2093
Amin Afrazi
Charlotte E Egan
Chhinder P Sodhi
Congrong Ma
David J Hackam
Dennis Slagle
Feras Alkhudari
George K Gittes
Hongpeng Jia
Ibrahim Yazji
P2860
P304
11330-11335
P356
10.1073/PNAS.1200856109
P407
P50
P577
2012-06-25T00:00:00Z